Table of Contents
Hepatitis Research and Treatment
Volume 2012, Article ID 317451, 8 pages
http://dx.doi.org/10.1155/2012/317451
Review Article

Deficient Knowledge on Hepatitis B Infection in Pregnant Women and Prevalence of Hepatitis B Surface Antigen Carriage in an Endemic Area: A Review

Department of Obstetrics and Gynaecology, Prince of Wales Hospital, The Chinese University of Hong Kong, Shatin, New Territories, Hong Kong

Received 29 February 2012; Accepted 29 August 2012

Academic Editor: Savino Bruno

Copyright © 2012 Oi Ka Chan et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. World Health Organization, “Hepatitis B,” Fact Sheet No. 204, World Health Organization, Geneva, Switzerland, 2000, http://www.who.int/mediacentre/factsheets/fs204/en/index.html. View at Google Scholar
  2. R. P. Beasley, L. Y. Hwang, C. C. Lin, and C. S. Chien, “Hepatocellular carcinoma and hepatitis B virus. A prospective study of 22 707 men in Taiwan,” The Lancet, vol. 2, no. 8256, pp. 1129–1133, 1981. View at Google Scholar · View at Scopus
  3. R. P. Beasley, “Hepatitis B virus as the etiologic agent in hepatocellular carcinoma—epidemiologic considerations,” Hepatology, vol. 2, supplement 2, pp. 21S–26S, 1982. View at Google Scholar · View at Scopus
  4. R. P. Beasley, “Hepatitis B virus. The major etiology of hepatocellular carcinoma,” Cancer, vol. 61, no. 10, pp. 1942–1956, 1988. View at Google Scholar · View at Scopus
  5. L. C. Kwan, Y. Y. Ho, and S. S. Lee, “The declining HBsAg carriage rate in pregnant women in Hong Kong,” Epidemiology and Infection, vol. 119, no. 2, pp. 281–283, 1997. View at Publisher · View at Google Scholar · View at Scopus
  6. Department of Health, Hong Kong, Surveillance of viral hepatitis in Hong Kong—2006 update report, http://www.info.gov.hk/hepatitis/doc/hepsurv06.pdf.
  7. C. Y. Chan, S. D. Lee, and K. J. Lo, “Legend of hepatitis B vaccination: the Taiwan experience,” Journal of Gastroenterology and Hepatology, vol. 19, no. 2, pp. 121–126, 2004. View at Publisher · View at Google Scholar · View at Scopus
  8. M. H. Chang, C. J. Chen, M. S. Lai et al., “Universal hepatitis B vaccination in Taiwan and the incidence of hepatocellular carcinoma in children,” The New England Journal of Medicine, vol. 336, no. 26, pp. 1855–1859, 1997. View at Publisher · View at Google Scholar · View at Scopus
  9. A. K. Y. Lee, H. M. H. Ip, and V. C. W. Wong, “Mechanisms of maternal-fetal transmission of hepatitis B virus,” Journal of Infectious Diseases, vol. 138, no. 5, pp. 668–671, 1978. View at Google Scholar · View at Scopus
  10. V. C. W. Wong, H. M. H. Ip, H. W. Reesink et al., “Prevention of the HBsAg carrier state in newborn infants of mothers who are chronic carriers of HBsAg and HBeAg by administration of hepatitis B vaccine and hepatitis B immunoglobulin. Double-blind randomised placebo-controlled study,” The Lancet, vol. 1, no. 8383, pp. 921–926, 1984. View at Google Scholar · View at Scopus
  11. S. S. H. Suen, T. T. Lao, D. S. Sahota, T. K. Lau, and T. Y. Leung, “Implications of the relationship between maternal age and parity with hepatitis B carrier status in a high endemicity area,” Journal of Viral Hepatitis, vol. 17, no. 5, pp. 372–378, 2010. View at Publisher · View at Google Scholar · View at Scopus
  12. O. K. Chan, T. T. Lao, S. S. H. Suen, T. K. Lau, and T. Y. Leung, “Correlation between maternal hepatitis B surface antigen carrier status with social, medical and family factors in an endemic area: have we overlooked something?” Infection, vol. 39, no. 5, pp. 419–426, 2011. View at Publisher · View at Google Scholar · View at Scopus
  13. O. K. Chan, T. T. Lao, S. S. H. Suen, T. K. Lau, and T. Y. Leung, “Knowledge on hepatitis B infection among pregnant women in a high endemicity area,” Patient Education and Counseling, vol. 85, no. 3, pp. 516–520, 2010. View at Publisher · View at Google Scholar · View at Scopus
  14. M. J. Thompson, V. M. Taylor, J. C. Jackson et al., “Hepatitis B knowledge and practices among Chinese American women in Seattle, Washington,” Journal of Cancer Education, vol. 17, no. 4, pp. 222–226, 2002. View at Google Scholar · View at Scopus
  15. M. J. Thompson, V. M. Taylor, Y. Yasui et al., “Hepatitis B knowledge and practices among Chinese Canadian Women in Vancouver, British Columbia,” Canadian Journal of Public Health, vol. 94, no. 4, pp. 281–286, 2003. View at Google Scholar · View at Scopus
  16. G. D. Coronado, V. M. Taylor, S. P. Tu et al., “Correlates of hepatitis B testing among Chinese Americans,” Journal of Community Health, vol. 32, no. 6, pp. 379–390, 2007. View at Publisher · View at Google Scholar · View at Scopus
  17. V. M. Taylor, S. P. Tu, E. Woodall et al., “Hepatitis B knowledge and practices among Chinese immigrants to the United States,” Asian Pacific Journal of Cancer Prevention, vol. 7, no. 2, pp. 313–317, 2006. View at Google Scholar · View at Scopus
  18. T. G. Hislop, C. Teh, A. Low et al., “Hepatitis B knowledge, testing and vaccination levels in Chinese immigrants to British Columbia, Canada,” Canadian Journal of Public Health, vol. 98, no. 2, pp. 125–129, 2007. View at Google Scholar · View at Scopus
  19. G. X. Ma, S. E. Shive, J. I. Toubbeh, Y. Tan, and D. Wu, “Knowledge, attitudes, and behaviors of Chinese hepatitis B screening and vaccination,” American Journal of Health Behavior, vol. 32, no. 2, pp. 178–187, 2008. View at Google Scholar · View at Scopus
  20. S. J. Cotler, S. Cotler, H. Xie, B. J. Luc, T. J. Layden, and S. S. Wong, “Characterizing hepatitis B stigma in Chinese immigrants,” Journal of Viral Hepatitis, vol. 19, no. 2, pp. 147–152, 2012. View at Publisher · View at Google Scholar · View at Scopus
  21. P. W. Chung, S. H. Suen, O. K. Chan, T. H. Lao, and T. Y. Leung, “Awareness and knowledge of hepatitis B infection and prevention and the use of hepatitis B vaccination in the Hong Kong adult Chinese population,” Chinese Medical Journal, vol. 125, no. 3, pp. 422–427, 2012. View at Google Scholar
  22. C. M. Leung, W. H. Wong, K. H. Chan et al., “Public awareness of hepatitis B infection: a population-based telephone survey in Hong Kong,” Hong Kong Medical Journal, vol. 16, no. 6, pp. 463–469, 2010. View at Google Scholar · View at Scopus
  23. J. L. Yao, “Perinatal transmission of hepatitis B virus infection and vaccination in China,” Gut, vol. 38, supplement 2, pp. S37–S38, 1996. View at Google Scholar · View at Scopus
  24. J. Hou, Z. Liu, and F. Gu, “Epidemiology and prevention of hepatitis B virus infection,” International Journal of Medical Sciences, vol. 2, no. 1, pp. 50–57, 2005. View at Google Scholar · View at Scopus
  25. Y. Poovorawan, S. Sanpavat, W. Pongpunlert, S. Chumdermpadetsuk, P. Sentrakul, and A. Safary, “Protective efficacy of a recombinant DNA hepatitis B vaccine in neonates of HBe antigen-positive mothers,” The Journal of the American Medical Association, vol. 261, no. 22, pp. 3278–3281, 1989. View at Google Scholar · View at Scopus
  26. C. Y. Lee, L. M. Huang, M. H. Chang et al., “The protective efficacy of recombinant hepatitis B vaccine in newborn infants of hepatitis B e antigen-positive-hepatitis B surface antigen carrier mothers,” Pediatric Infectious Disease Journal, vol. 10, no. 4, pp. 299–303, 1991. View at Google Scholar · View at Scopus
  27. R. P. Beasley, L. Y. Hwang, C. C. Lin et al., “Hepatitis B immune globulin (HBIG) efficacy in the interruption of perinatal transmission of hepatitis B virus carrier state. Initial report of a randomised double-blind placebo-controlled trial,” The Lancet, vol. 2, no. 8243, pp. 388–393, 1981. View at Google Scholar · View at Scopus
  28. E. K. Yeoh, “Hepatitis B vaccination—who should be vaccinated?” Journal of the Hong Kong Medical Association, vol. 39, pp. 208–209, 1987. View at Google Scholar
  29. P. I. Lee, C. Y. Lee, L. M. Huang, J. M. Chen, and M. H. Chang, “A follow-up study of combined vaccination with plasma-derived and recombinant hepatitis B vaccines in infants,” Vaccine, vol. 13, no. 17, pp. 1685–1689, 1995. View at Publisher · View at Google Scholar · View at Scopus
  30. R. P. Beasley, L. Y. Hwang, C. E. Stevens et al., “Efficacy of hepatitis B immune globulin for prevention of perinatal transmission of the hepatitis B virus carrier state: final report of a randomized double-blind, placebo-controlled trial,” Hepatology, vol. 3, no. 2, pp. 135–141, 1983. View at Google Scholar · View at Scopus
  31. A. S. F. Lok, “Hepatitis B vaccination in Hong Kong,” Journal of Gastroenterology and Hepatology, vol. 8, supplement 1, pp. S27–S29, 1993. View at Google Scholar
  32. H. Obata, N. Hayashi, Y. Motoike et al., “A prospective study on the development of hepatocellular carcinoma from liver cirrhosis with persistent hepatitis B virus infection,” International Journal of Cancer, vol. 25, no. 6, pp. 741–747, 1980. View at Google Scholar · View at Scopus
  33. K. C. Hyams, “Risks of chronicity following acute hepatitis B virus infection: a review,” Clinical Infectious Diseases, vol. 20, no. 4, pp. 992–1000, 1995. View at Google Scholar · View at Scopus
  34. M. J. Alter and H. S. Margolis, “The emergence of hepatitis B as a sexually transmitted disease,” Medical Clinics of North America, vol. 74, no. 6, pp. 1529–1541, 1990. View at Google Scholar · View at Scopus
  35. L. Simonsen, A. Kane, J. Lloyd, M. Zaffran, and M. Kane, “Unsafe injections in the developing world and transmission of bloodborne pathogens: a review,” Bulletin of the World Health Organization, vol. 77, no. 10, pp. 789–800, 1999. View at Google Scholar · View at Scopus
  36. A. Kane, J. Lloyd, M. Zaffran, L. Simonsen, and M. Kane, “Transmission of hepatitis B, hepatitis C and human immunodeficiency viruses through unsafe injections in the developing world: model-based regional estimates,” Bulletin of the World Health Organization, vol. 77, no. 10, pp. 801–807, 1999. View at Google Scholar · View at Scopus
  37. J. T. Dongdem, S. Kampo, I. N. Soyiri, P. N. Asebga, J. B. Ziem, and K. Sagoe, “Prevalence of hepatitis B virus infection among blood donors at the Tamale Teaching Hospital, Ghana (2009),” BMC Research Notes, vol. 5, no. 1, article 115, 2012. View at Google Scholar
  38. J. Heathcote, C. H. Cameron, and D. S. Dane, “Hepatitis B antigen in saliva and semen,” The Lancet, vol. 1, no. 7847, pp. 71–73, 1974. View at Google Scholar · View at Scopus
  39. G. R. Irwin, A. M. Allen, W. H. Bancroft et al., “Hepatitis B antigen in saliva, urine, and stool,” Infection and Immunity, vol. 11, no. 1, pp. 142–145, 1975. View at Google Scholar · View at Scopus
  40. S. V. Feinman, O. Krassnitski, J. C. Sinclair, D. M. Wrobel, and B. Berris, “Hepatitis B surface antigen in saliva of HB(s)Ag carriers,” Journal of Laboratory and Clinical Medicine, vol. 85, no. 6, pp. 1042–1048, 1975. View at Google Scholar · View at Scopus
  41. H. Ben-Aryeh, I. Ur, and E. Ben-Porath, “The relationship between antigenaemia and excretion of hepatitis B surface antigen in human whole saliva and in gingival crevicular fluid,” Archives of Oral Biology, vol. 30, no. 1, pp. 97–99, 1985. View at Google Scholar · View at Scopus
  42. S. J. Cunningham, R. Cunningham, M. G. A. Izmeth, B. Baker, and C. A. Hart, “Seroprevalence of hepatitis B and C in a Merseyside hospital for the mentally handicapped,” Epidemiology and Infection, vol. 112, no. 1, pp. 195–200, 1994. View at Google Scholar · View at Scopus
  43. A. A. van der Eijk, H. G. M. Niesters, H. M. Götz et al., “Paired measurements of quantitative hepatitis B virus DNA in saliva and serum of chronic hepatitis B patients: implications for saliva as infectious agent,” Journal of Clinical Virology, vol. 29, no. 2, pp. 92–94, 2004. View at Publisher · View at Google Scholar · View at Scopus
  44. K. Kidd-Ljunggren, A. Holmberg, J. Bläckberg, and B. Lindqvist, “High levels of hepatitis B virus DNA in body fluids from chronic carriers,” Journal of Hospital Infection, vol. 64, no. 4, pp. 352–357, 2006. View at Publisher · View at Google Scholar · View at Scopus
  45. I. L. Heiberg, M. Hoegh, S. Ladelund, H. G. M. Niesters, and B. Hogh, “Hepatitis B virus dna in saliva from children with chronic hepatitis B infection: implications for saliva as a potential mode of horizontal transmission,” Pediatric Infectious Disease Journal, vol. 29, no. 5, pp. 465–467, 2010. View at Publisher · View at Google Scholar · View at Scopus
  46. A. Y. Hui, L. C. T. Hung, P. C. H. Tse, W. K. Leung, P. K. S. Chan, and H. L. Y. Chan, “Transmission of hepatitis B by human bite—confirmation by detection of virus in saliva and full genome sequencing,” Journal of Clinical Virology, vol. 33, no. 3, pp. 254–256, 2005. View at Publisher · View at Google Scholar · View at Scopus
  47. R. M. Scott, R. Snitbhan, W. H. Bancroft, H. J. Alter, and M. Tingpalapong, “Experimental transmission of hepatitis B virus by semen and saliva,” Journal of Infectious Diseases, vol. 142, no. 1, pp. 67–71, 1980. View at Google Scholar · View at Scopus
  48. T. P. Cancio Bello, M. de Medina, J. Shorey, M. D. Valledor, and E. R. Schiff, “An institutional outbreak of hepatitis B related to a human biting carrier,” Journal of Infectious Diseases, vol. 146, no. 5, pp. 652–656, 1982. View at Google Scholar · View at Scopus
  49. C. Stornello, “Transmission of hepatitis B via human bite,” The Lancet, vol. 338, no. 8773, pp. 1024–1025, 1991. View at Google Scholar · View at Scopus
  50. I. J. B. Spijkerman, L. J. van Doorn, M. H. W. Janssen et al., “Transmission of hepatitis B virus from a surgeon to his patients during high-risk and low-risk surgical procedures during 4 years,” Infection Control and Hospital Epidemiology, vol. 23, no. 6, pp. 306–312, 2002. View at Google Scholar · View at Scopus
  51. C. Lobato, J. Tavares-Neto, M. Rios-Leite et al., “Intrafamilial prevalence of hepatitis B virus in Western Brazilian Amazon region: epidemiologic and biomolecular study,” Journal of Gastroenterology and Hepatology, vol. 21, no. 5, pp. 863–868, 2006. View at Publisher · View at Google Scholar · View at Scopus
  52. N. J. Petersen, D. H. Barrett, W. W. Bond et al., “Hepatitis B surface antigen in saliva, impetiginous lesions, and the environment in 2 remote Alaskan villages,” Applied and Environmental Microbiology, vol. 32, no. 4, pp. 572–574, 1976. View at Google Scholar · View at Scopus
  53. W. W. Bond, M. S. Favero, N. J. Petersen, C. R. Gravelle, J. W. Ebert, and J. E. Maynard, “Survival of hepatitis B virus after drying and storage for one week,” The Lancet, vol. 1, no. 8219, pp. 550–551, 1981. View at Google Scholar · View at Scopus
  54. R. Zachoval, G. Frösner, F. Deinhardt, and D. Höss, “Persistence of hepatitis B virus antigens in dried blood,” The Lancet, vol. 1, no. 8223, article 778, 1981. View at Google Scholar · View at Scopus
  55. K. T. Goh, J. L. Ding, E. H. Monteiro, and C. J. Oon, “Hepatitis B infection in households of acute cases,” Journal of Epidemiology and Community Health, vol. 39, no. 2, pp. 123–128, 1985. View at Google Scholar · View at Scopus
  56. O. K. Chan, S. S. H. Suen, T. T. H. Lao, V. K. T. Leung, S. W. Yeung, and T. Y. Leung, “Determinants of hepatitis B vaccine uptake among pregnant Chinese women in Hong Kong,” International Journal of Gynecology and Obstetrics, vol. 106, no. 3, pp. 232–235, 2009. View at Publisher · View at Google Scholar · View at Scopus
  57. A. Mele, R. Corona, M. E. Tosti et al., “Beauty treatments and risk of parenterally transmitted hepatitis: results from the hepatitis surveillance system in Italy,” Scandinavian Journal of Infectious Diseases, vol. 27, no. 5, pp. 441–444, 1995. View at Google Scholar · View at Scopus
  58. A. Mariano, A. Mele, M. E. Tosti et al., “Role of beauty treatment in the spread of parenterally transmitted hepatitis viruses in Italy,” Journal of Medical Virology, vol. 74, no. 2, pp. 216–220, 2004. View at Publisher · View at Google Scholar
  59. Department of Health, Viral Hepatitis Preventive Service, http://www.info.gov.hk/hepatitis.
  60. C. Davis, M. B. Noel, S. F. F. Chan, and L. S. Wing, “Knowledge, attitudes and behaviours related to HIV and AIDS among Chinese adolescents in Hong Kong,” Journal of Adolescence, vol. 21, no. 6, pp. 657–665, 1998. View at Publisher · View at Google Scholar · View at Scopus
  61. C. S. Chu, T. W. Chan, H. M. Hui, L. P. Samaranayake, J. C. Chan, and S. H. Wei, “The knowledge and attitude of Hong Kong secondary school teachers and students towards HIV infection and dentistry,” Community Dental Health, vol. 12, no. 2, pp. 110–114, 1995. View at Google Scholar · View at Scopus
  62. Ministry of Health of the People's Republic of China, 2009, http://medicine.people.com.cn/GB/135894/178335/index.html.